|
U.S. FDA Guidance Outlines Device Risk, Benefit Analysis
To illustrate how reviewers analyze device applications and make their recommendations for approval, a new U.S. Food and Drug Administration (FDA) draft guidance distills benefit-risk analysis of devices into a series of topics and questions and offers a worksheet on key considerations.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives